Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
–bio interactions: Study cellular responses to nanozyme-coated implants, including cytocompatibility, macrophage activation, cytokine production and parameters related to osteointe-gration. Study
-
to the systems we are building in this space. The work spans methodological research and concrete implementation, and treats questions of reliability, accountability, and human-AI interaction as research questions
-
Cornelia Krug, and Dr Ute Jacob. Access to UZH expertise in ecological stability, response diversity, landscape sustainability, human-environment interactions, spatial modelling, data science, and the
-
systems. To get an overview of our lab's recent projects, take a look at our publications: https://drescherlab.org/publications.html We are looking for a highly motivated and talented PhD student to join
-
to further develop concepts in nonlinear model reduction Possible research directions include the development of nonlinear modelling and control approaches for fluid-structure interactions, material with
-
, but to drive innovative research and achieve decisive progress. Further details on NCCR Genesis are available on its website https://nccr-genesis.ch . Job description The successful candidate will
-
. The project is jointly supervised within an ETH collaborative initiative, providing the student with regular interaction with the groups of Prof. Dikopoltsev, Prof. Scalari, Prof. Johnson, and the project
-
geochemistry, Earth sciences, environmental chemistry, chemistry, or a closely related discipline. A strong interest or background in low-temperature geochemistry, water-rock interactions, mineral formation
-
. It will explore questions such as whether individuals who use AI chatbots for social aims will start interacting less with their friends and family or whether certain uses of AI chatbots can improve
-
of dynamic polymer networks; (ii) (bio)material processing; (iii) organ perfusion and regeneration; (iv) tools to study mechanobiology and cell–matrix interactions; and (v) engineered drug delivery